MARIMED INC.·4

Jun 12, 4:42 PM ET

Allen David R 4

Research Summary

AI-generated summary

Updated

Marimed (MRMD) Director David R. Allen Converts RSUs, Disposes 75,000 Shares

What Happened David R. Allen, a director of Marimed Inc. (MRMD), had RSUs convert into common stock and an offsetting disposition on June 12, 2026. The Form 4 shows an acquisition of 75,000 shares at $0.00 (conversion/exercise of a derivative, code M) and a simultaneous disposition of 75,000 shares at $0.00 (derivative). The reported price for both entries is $0.00, which reflects conversion/settlement of RSUs rather than a cash purchase price; no cash value is reported on the Form 4 entries provided.

Key Details

  • Transaction date: 2026-06-12
  • Transaction types/codes: M = exercise/conversion of derivative (RSU conversion reported as acquisition and derivative disposition)
  • Shares: 75,000 acquired at $0.00; 75,000 disposed at $0.00
  • Shares owned after transaction: Not specified in the supplied filing
  • Footnotes: F1 — RSUs convert to common stock on a one-for-one basis. F2 — These RSUs were originally granted on June 12, 2025 and there are no RSUs remaining under that grant per the award agreement.
  • Timeliness: Report filed on 2026-06-12 (same day), indicating a timely filing.

Context Code M in Form 4 filings generally denotes the exercise or conversion of a derivative security (here, RSUs converting to shares). The $0.00 price typically indicates conversion/settlement rather than a cash purchase; the filing does not state the reason for the simultaneous disposition (e.g., sale, transfer, or tax-withholding). These transactions are informational for investors but do not by themselves indicate management’s market view.